Software for Dosage Individualization of Voriconazole: a Prospective Clinical Study

Voriconazole is a first-line antifungal agent. Therapeutic drug monitoring is a standard of care. The best way to adjust dosages to achieve desired drug exposure endpoints is unclear due to nonlinear and variable pharmacokinetics. Previously described software was used to prospectively adjust vorico...

Descripción completa

Detalles Bibliográficos
Autores principales: Hope, William, Johnstone, Gary, Cicconi, Silvia, Felton, Timothy, Goodwin, Joanne, Whalley, Sarah, Santoyo-Castelazo, Anahi, Ramos-Martin, Virginia, Lestner, Jodi, Credidio, Leah, Dane, Aaron, Carr, Daniel F., Pirmohamed, Munir, Salim, Rahim, Neely, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2019
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6496160/
https://www.ncbi.nlm.nih.gov/pubmed/30670416
http://dx.doi.org/10.1128/AAC.02353-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6496160/
https://www.ncbi.nlm.nih.gov/pubmed/30670416
http://dx.doi.org/10.1128/AAC.02353-18

Ejemplares similares